Team
Dr. Emily Vandermeer, PhD
Dr. Emily Vandermeer is a leading biomedical scientist with over 20 years of experience in medical product innovation. She holds a PhD in Biomedical Engineering from MIT, where her research focused on biomaterials for drug delivery systems. Throughout her career, Dr. Vandermeer has led numerous projects that have resulted in groundbreaking medical devices now used globally. She is currently the Director of Research and Development at MedInnovate, where she oversees the development of next-generation medical technologies. Dr. Vandermeer has published over 50 peer-reviewed articles and holds 15 patents in medical device technology. She received the Innovator Award from the Biomedical Engineering Society in recognition of her contributions to the field. Her current work involves developing bioresorbable implants that reduce the need for revision surgeries, aiming to transform patient recovery processes worldwide.
Dr. Jordan Lee, MD, FACS
Dr. Jordan Lee is a respected surgeon and an Associate Professor of Surgery at Johns Hopkins University. He completed his medical degree at Harvard Medical School and his surgical residency at the University of California, San Francisco. Dr. Lee is board-certified in general surgery and holds a fellowship in surgical oncology from Memorial Sloan Kettering Cancer Center. With over 15 years of clinical experience, he specializes in minimally invasive techniques for cancer treatment, significantly improving patient recovery times. Dr. Lee has authored more than 40 articles in prestigious medical journals and has been awarded for his teaching excellence and patient care innovations. He regularly speaks at national and international conferences on the integration of new technologies in surgical practice, emphasizing the importance of precision medicine in oncology.
Dr. Sofia Griffin, PharmD, BCPS
Dr. Sofia Griffin is a distinguished pharmacist with an extensive background in clinical pharmacy and patient care. She earned her Doctor of Pharmacy degree from the University of North Carolina, where she also completed a residency in pharmacy practice. Sofia is Board Certified in Pharmacotherapy, a credential that underscores her expertise in managing complex medication therapies. Over her 15-year career, she has specialized in geriatric pharmacotherapy, providing targeted care to improve the quality of life for elderly patients. Sofia's exceptional contributions to pharmacy have been recognized with several awards, including the Pharmacist of the Year Award from her state pharmacy association. Her work not only demonstrates her deep commitment to patient care but also her leadership in advancing pharmacy practice. She is currently involved in several research projects aiming to optimize drug therapy for chronic diseases in aging populations.
Dr. Lucas Morgenthal, PhD, MEng
Dr. Lucas Morgenthal is an innovative expert in tissue engineering with a focus on regenerative medicine. He earned his Master's in Engineering from Stanford University and his PhD in Chemical Engineering from the University of Cambridge, specializing in stem cell technology. Over the past decade, Dr. Morgenthal has been pivotal in developing tissue scaffolds that facilitate the growth of organ-specific cells for transplant applications. He is currently a Senior Scientist at BioRegen Corp, where he leads a team focused on engineering functional organs for clinical use. His work has garnered him the Rising Star Award in Regenerative Medicine. Dr. Morgenthal has published extensively, contributing over 30 articles to top-tier scientific journals. His latest project involves the use of bioprinting technologies to create viable heart tissues for patients with cardiac diseases, which has the potential to revolutionize heart transplant methodologies.
Dr. Anita Desai, MD, MPH
Dr. Anita Desai is an accomplished public health specialist and epidemiologist, holding an MD from the University of Michigan and a Master of Public Health (MPH) from Johns Hopkins Bloomberg School of Public Health. Her career spans over 18 years, focusing on the epidemiology of infectious diseases and public health policy. Dr. Desai has worked with the World Health Organization and the Centers for Disease Control and Prevention on global health initiatives, particularly in controlling outbreaks of emerging viruses. Currently, she serves as the Director of Public Health Policy at Global Health Solutions. Dr. Desai has been instrumental in designing disease surveillance programs that have been adopted internationally. She has received numerous awards for her leadership in global health and has over 60 publications in the field. Her ongoing work includes developing strategies for pandemic preparedness, aiming to enhance global responses to infectious disease threats.